Cas no 17059-27-7 (Card-20(22)-enolide,3-[(6-deoxy-4-O-b-D-glucopyranosyl-3-O-methyl-b-D-glucopyranosyl)oxy]-14-hydroxy-,(3b,5b)- (9CI))
![Card-20(22)-enolide,3-[(6-deoxy-4-O-b-D-glucopyranosyl-3-O-methyl-b-D-glucopyranosyl)oxy]-14-hydroxy-,(3b,5b)- (9CI) structure](https://ossimg.kuujia.com/scimg/17500/17059-27-7x500.png)
17059-27-7 structure
Product Name:Card-20(22)-enolide,3-[(6-deoxy-4-O-b-D-glucopyranosyl-3-O-methyl-b-D-glucopyranosyl)oxy]-14-hydroxy-,(3b,5b)- (9CI)
CAS No:17059-27-7
MF:C36H56O13
MW:696.822052955627
CID:183377
Update Time:2024-03-01
Card-20(22)-enolide,3-[(6-deoxy-4-O-b-D-glucopyranosyl-3-O-methyl-b-D-glucopyranosyl)oxy]-14-hydroxy-,(3b,5b)- (9CI) Chemical and Physical Properties
Names and Identifiers
-
- Card-20(22)-enolide,3-[(6-deoxy-4-O-b-D-glucopyranosyl-3-O-methyl-b-D-glucopyranosyl)oxy]-14-hydroxy-,(3b,5b)- (9CI)
- ObebiosideA
- Card-20(22)-enolide, 3-[(6-deoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-glucopyranosyl)oxy]-14-hydroxy-, (3β,5β)-
-
- Inchi： 1S/C36H56O13/c1-17-30(49-32-28(41)27(40)26(39)24(15-37)48-32)31(44-4)29(42)33(46-17)47-20-7-10-34(2)19(14-20)5-6-23-22(34)8-11-35(3)21(9-12-36(23,35)43)18-13-25(38)45-16-18/h13,17,19-24,26-33,37,39-43H,5-12,14-16H2,1-4H3/t17-,19-,20+,21-,22+,23-,24-,26-,27+,28-,29-,30-,31-,32+,33+,34+,35-,36+/m1/s1
- InChI Key： LBCSKUSUYQVKDB-CWIMVSJKSA-N
- SMILES： [C@@H]1(O[C@@H]2O[C@H](C)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](OC)[C@H]2O)C[C@]2([H])[C@](C)(CC1)[C@]1([H])[C@]([H])([C@]3(O)[C@@](CC1)(C)[C@@H](C1=CC(=O)OC1)CC3)CC2
Computed Properties
- Exact Mass: 272.08309
Experimental Properties
- Density: 1.38±0.1 g/cm3(Predicted)
- Boiling Point: 856.7±65.0 °C(Predicted)
- PSA: 52.54
- pka: 12.79±0.70(Predicted)
Card-20(22)-enolide,3-[(6-deoxy-4-O-b-D-glucopyranosyl-3-O-methyl-b-D-glucopyranosyl)oxy]-14-hydroxy-,(3b,5b)- (9CI) Related Literature
-
1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
-
Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
-
4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
-
Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
17059-27-7 (Card-20(22)-enolide,3-[(6-deoxy-4-O-b-D-glucopyranosyl-3-O-methyl-b-D-glucopyranosyl)oxy]-14-hydroxy-,(3b,5b)- (9CI)) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)
Recommended suppliers
Changzhou Guanjia Chemical Co., Ltd
Gold Member
Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm
Gold Member
Audited Supplier
CN Supplier
Bulk
Zhejiang Brunova Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
SunaTech Inc.
Gold Member
Audited Supplier
CN Supplier
Reagent
